Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 27 Nausea 17 Neoplasms 12 Breast Neoplasms 4 Multiple Myeloma 2 Lymphoma 2 Leukemia 2 Hematologic Neoplasms 2 Breast Neoplasms, Male 2 Weight Loss 1 Solid Tumors 1 Sarcoma 1 Rectal Neoplasms 1 Pain 1 Nausea With Vomiting Chemotherapy-Induced 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Glioma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Anorexia 1

Interventions

Fentanyl 19 Analgesia 15 Acupuncture Therapy 13 Oxycodone 12 Zoledronic Acid 11 Surveys and Questionnaires 10 nabiximols 9 Therapeutics 9 Morphine 9 Acetaminophen 9 Psychiatric Rehabilitation 8 Ketamine 8 Hydromorphone 7 Lidocaine 6 Ibandronic Acid 6 Radiotherapy 5 Early Intervention, Educational 5 Bupivacaine 5 Analgesics, Opioid 5 Yoga 4 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Ropivacaine 4 Music Therapy 4 Methadone 4 Massage 4 Aromatherapy 4 alvimopan 3 Tapentadol 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05315999 2025-03-19

ProTreat

University Hospital Freiburg

Phase 2 Completed

Nausea, Pain, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡